Cancer Metastasis

Table of Contents

1. Altmetric Badge
   Book Overview
2. Altmetric Badge
   Chapter 1 Metastasis: The Clinical Problem
3. Altmetric Badge
   Chapter 2 The Nude Mouse Model for Studies of Human Cancer Metastasis
4. Altmetric Badge
   Chapter 3 Tumor Cells Genetically Tagged with Transferred DNA Markers Reveal Evidence for Clonal Dominance of Primary Tumors by Metastatic Subpopulations
5. Altmetric Badge
   Chapter 4 Oncogenes and Tumor Progression: State of the Art
6. Altmetric Badge
   Chapter 5 Genetic Analysis of Invasive and Metastatic Capacity in T Lymphoma Cells
7. Altmetric Badge
   Chapter 6 Transforming Growth Factor-Beta: Possible Roles in Carcinogenesis
8. Altmetric Badge
   Chapter 7 Altered Gene Expression in Tumor Metastasis: The nm23 Gene
9. Altmetric Badge
   Chapter 8 In Vivo Observations on Tumor Invasion
10. Altmetric Badge
    Chapter 9 Metastatic Phenotype and Cell Differentiation in Melanoma Cells
11. Altmetric Badge
    Chapter 10 Adhesive, Invasive, and Growth Properties of Organ-Specific Metastatic Cells
12. Altmetric Badge
    Chapter 11 Importance of Cell Surface Carbohydrates in Tumor Cell Metastasis
13. Altmetric Badge
    Chapter 12 Cell Shape and the Metastatic Phenotype
14. Altmetric Badge
    Chapter 13 Cell Surface Plasminogen Activation
15. Altmetric Badge
    Chapter 14 Adhesion Mechanisms in Lymphoma Invasion and Metastasis
16. Altmetric Badge
    Chapter 15 The Role of Macrophages in the Regulation of Tumor Growth and Metastasis
17. Altmetric Badge
    Chapter 16 The Influence of Murine and Human Major Histocompatibility Complex Class I Expression on Tumor Growth and Metastasis
18. Altmetric Badge
    Chapter 17 Identification of Point Mutations in Genes Coding for tum-Antigens. A Step Towards the Understanding of Mouse and Human Tumor-Specific Transplantation Antigens?
19. Altmetric Badge
    Chapter 18 Recognition of the HLA Class II-Peptide Complex by T cell Receptor: Reversal of MHC Restriction of a T Cell Clone by a Point Mutation in the Peptide Determinant
20. Altmetric Badge
    Chapter 19 Regulatory Aspects of the Antitumor Immune Response
21. Altmetric Badge
    Chapter 20 Active Specific Immunotherapy with Autologous Tumor Cell Vaccines Modified by Newcastle Disease Virus: Experimental and Clinical Studies
22. Altmetric Badge
    Chapter 21 The Effect of Interferon on Experimental Tumor Metastases
23. Altmetric Badge
    Chapter 22 Injections of Interleukins Around Tumor-Draining Lymph Nodes: A New Mode of Immunotherapy
24. Altmetric Badge
    Chapter 23 Autolymphocyte Therapy: An Outpatient, Low-Toxicity Approach to Adoptive Immunotherapy
25. Altmetric Badge
    Chapter 24 Active Specific Immunotherapy of Colorectal Cancer
26. Altmetric Badge
    Chapter 25 Review of Experience in Clinical Trials of Specific Active Tumor-Associated Antigen Immunotherapy of Lung Cancer
27. Altmetric Badge
    Chapter 26 Metastasis: Growth and Pathogenesis, Models, and Mechanisms
28. Altmetric Badge
    Chapter 27 Metastasis: Diagnosis and Targeting, Genetic Changes
29. Altmetric Badge
    Chapter 28 Metastasis: Adhesion, Lectin-Carbohydrate Interaction, Organotropism, Growth Factors
30. Altmetric Badge
    Chapter 29 Invasion, Matrix Degradation, Angiogenesis, Motility
31. Altmetric Badge
    Chapter 30 Metastatic Phenotype and Cell Differentiation
32. Altmetric Badge
    Chapter 31 Microenvironmental Factors, Hormones, and Signal Transduction
33. Altmetric Badge
    Chapter 32 Tumor Immunology
34. Altmetric Badge
    Chapter 33 Immunotherapy Studies
35. Altmetric Badge
    Chapter 34 Therapy: Chemo-, Hormone- and Radiotherapy, Surgery
36. Altmetric Badge
    Chapter 35 The First Paget-Ewing Award Ceremony
37. Altmetric Badge
    Chapter 36 Laudatio for Professor Irwing Zeidman
38. Altmetric Badge
    Chapter 37 Surgery, Radiotherapy, Chemotherapy, Hormonal Therapy
39. Altmetric Badge
    Chapter 38 Bone Marrow Transplantation, Monoclonal Antibodies, Growth Factor Antagonists, Colony-Stimulating Factors
40. Altmetric Badge
    Chapter 39 Adoptive Immunotherapy, Active Specific Immunotherapy, Biological Response Modifiers